Characteristics and Outcomes of Heart Transplant Recipients With Coronavirus-19 Disease in a High-volume Transplant Center
Carregando...
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Citação
TRANSPLANTATION, v.106, n.3, p.641-647, 2022
Resumo
Background. Heart transplant (HT) recipients may be at higher risk of acquiring SARS-CoV-2 infection and developing critical illness. The aim of this study is to describe characteristics and outcomes of HT recipients infected by SARS-COV-2, from a high-volume transplant center. Methods. We have described data of all adult HT recipients with confirmed coronavirus disease 2019 by RT-PCR in nasopharyngeal samples from April 5, 2020, to January 5, 2021. Outcomes and follow-up were recorded until February 5, 2021. Results. Forty patients were included. Twenty-four patients (60%) were men; the median age was 53 (40-60) y old; median HT time was 34 mo; and median follow-up time 162 d. The majority needed hospitalization (83%). Immunosuppressive therapy was reduced/withdrawn in the majority of patients, except from steroids, which were maintained. Seventeen patients (42.5%) were classified as having severe disease according to the ordinal scale developed by the World Health Organization Committee. They tended to have lower absolute lymphocyte count (P < 0.001) during follow-up when compared with patients with mild disease. Thirty-day mortality was 12.5%. However, a longer follow-up revealed increased later mortality (27.5%), with median time to death around 35 d. Bacterial nosocomial infections were a leading cause of death. Cardiac allograft rejection (10%) and ventricular dysfunction (12.5%) were also not negligible. Conclusions. Major findings of this study corroborate other cohorts' results, but it also reports significant rate of later events, suggesting that a strict midterm surveillance is advisable to HT recipients with coronavirus disease 2019.
Palavras-chave
Referências
- Akalin E, 2020, NEW ENGL J MED, V382, P2475, DOI 10.1056/NEJMc2011117
- Alberici F, 2020, KIDNEY INT REP, V5, P580, DOI 10.1016/j.ekir.2020.04.001
- Ali T, 2021, TRANSPLANTATION, V105, P121, DOI 10.1097/TP.0000000000003433
- Avery RK, 2021, TRANSPLANTATION, V105, P56, DOI 10.1097/TP.0000000000003519
- Azzi Y, 2021, TRANSPLANTATION, V105, P37, DOI 10.1097/TP.0000000000003523
- Bottio T, 2021, JACC-HEART FAIL, V9, P52, DOI 10.1016/j.jchf.2020.10.009
- Buetti N, 2021, INTENS CARE MED, V47, P180, DOI 10.1007/s00134-021-06346-w
- Caillard S, 2020, KIDNEY INT, V98, P1549, DOI 10.1016/j.kint.2020.08.005
- Chapman JR, 2021, TRANSPLANTATION, V105, P1, DOI 10.1097/TP.0000000000003544
- Clancy CJ, 2020, JAC-ANTIMICROB RESIS, V2, DOI 10.1093/jacamr/dlaa049
- Coll E, 2021, AM J TRANSPLANT, V21, P1825, DOI 10.1111/ajt.16369
- Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
- Cravedi P, 2020, AM J TRANSPLANT, V20, P3140, DOI 10.1111/ajt.16185
- Crespo M, 2020, AM J TRANSPLANT, V20, P2883, DOI 10.1111/ajt.16096
- Felldin M, 2021, TRANSPLANTATION, V105, P108, DOI 10.1097/TP.0000000000003436
- Fernandez-Ruiz M, 2020, AM J TRANSPLANT, V20, P1849, DOI 10.1111/ajt.15929
- Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
- Kates Olivia S, 2021, Clin Infect Dis, V73, pe4090, DOI 10.1093/cid/ciaa1097
- Kutzler HL, 2021, TRANSPLANTATION, V105, pE6, DOI 10.1097/TP.0000000000003495
- Langford BJ, 2020, CLIN MICROBIOL INFEC, V26, P1622, DOI 10.1016/j.cmi.2020.07.016
- Latif F, 2020, JAMA CARDIOL, V5, P1165, DOI 10.1001/jamacardio.2020.2159
- Lee K, 2009, GLOB INST, P1
- Li J, 2021, J MED VIROL, V93, P1449, DOI 10.1002/jmv.26424
- Ministerio da Saude, 2021, PAIN COR
- Pereira MR, 2020, AM J TRANSPLANT, V20, P1800, DOI 10.1111/ajt.15941
- Rivinius R, 2020, CLIN RES CARDIOL, V109, P1531, DOI 10.1007/s00392-020-01722-w
- Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012
- Tschopp J, 2020, AM J TRANSPLANT, V20, P2876, DOI 10.1111/ajt.16062
- WHO R&D Blueprint, 2020, NOV COR COVID 19 THE
- Yi SG, 2020, TRANSPLANTATION, V104, P2208, DOI 10.1097/TP.0000000000003339
- Zaidan M, 2021, TRANSPLANTATION, V105, P61, DOI 10.1097/TP.0000000000003536
- Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
- Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
Coleções
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - LIM/47
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - LIM/47
Artigos e Materiais de Revistas Científicas - ODS/03